D Liolitsa1, J Powell, S Lovestone. 1. Department of Neuroscience and Department of Old Age Psychiatry, Institute of Psychiatry, Denmark Hill, SE5 8AF, London, UK. d.liolitsa@ion.ucl.uk
Abstract
OBJECTIVE: To test the hypothesis that polymorphic variation in insulin signalling genes may underlie the shared risk of dysfunctional insulin signalling and late onset Alzheimer's disease (AD). The p85alpha subunit of phosphatidyl inositol 3 kinase (PIK3R1) and the regulatory subunit 3 of protein phosphatase 1 (PPP1R3) were selected as candidate genes because both encode key proteins involved in insulin signalling and because polymorphisms in these genes have been previously implicated in insulin resistance or type II diabetes. METHODS: Analysis of the Met326Ile PIK3R1 and the Asp905Tyr PPP1R3 polymorphisms in 202 patients with late onset AD and 160 or 170 age matched normal subjects. RESULTS: Logistic regression analysis using the recessive genetic model showed significant differences in genotype and allelic frequencies between the AD group and normal controls (genotypes: odds ratio (OR) 2.09, 95% confidence interval (CI) 1.17 to 3.74, p = 0.01; alleles: OR 1.99, 95% CI 1.17 to 3.40, p = 0.01) for the Met326Ile PIK3R1 polymorphism that were female specific. Additionally, in the dominant genetic model a marginally significant association in genotype frequencies between the Asp905Tyr PPP1R3 polymorphism and AD was observed (genotypes: OR 1.85, 95% CI 1.03 to 3.30, p = 0.04; alleles: OR 1.68, 95% CI 0.98 to 2.88, p = 0.06). Both polymorphisms were tested for their interactions with sex and the presence of the apolipoprotein E epsilon 4 allele. CONCLUSIONS: The results support the hypothesis for a common genetic aetiology predisposing to insulin resistance and AD.
OBJECTIVE: To test the hypothesis that polymorphic variation in insulin signalling genes may underlie the shared risk of dysfunctional insulin signalling and late onset Alzheimer's disease (AD). The p85alpha subunit of phosphatidyl inositol 3 kinase (PIK3R1) and the regulatory subunit 3 of protein phosphatase 1 (PPP1R3) were selected as candidate genes because both encode key proteins involved in insulin signalling and because polymorphisms in these genes have been previously implicated in insulin resistance or type II diabetes. METHODS: Analysis of the Met326IlePIK3R1 and the Asp905TyrPPP1R3 polymorphisms in 202 patients with late onset AD and 160 or 170 age matched normal subjects. RESULTS: Logistic regression analysis using the recessive genetic model showed significant differences in genotype and allelic frequencies between the AD group and normal controls (genotypes: odds ratio (OR) 2.09, 95% confidence interval (CI) 1.17 to 3.74, p = 0.01; alleles: OR 1.99, 95% CI 1.17 to 3.40, p = 0.01) for the Met326IlePIK3R1 polymorphism that were female specific. Additionally, in the dominant genetic model a marginally significant association in genotype frequencies between the Asp905TyrPPP1R3 polymorphism and AD was observed (genotypes: OR 1.85, 95% CI 1.03 to 3.30, p = 0.04; alleles: OR 1.68, 95% CI 0.98 to 2.88, p = 0.06). Both polymorphisms were tested for their interactions with sex and the presence of the apolipoprotein E epsilon 4 allele. CONCLUSIONS: The results support the hypothesis for a common genetic aetiology predisposing to insulin resistance and AD.
Authors: R A Hegele; S B Harris; B Zinman; J Wang; H Cao; A J Hanley; L C Tsui; S W Scherer Journal: J Clin Endocrinol Metab Date: 1998-11 Impact factor: 5.958
Authors: S Craft; S Asthana; G Schellenberg; L Baker; M Cherrier; A A Boyt; R N Martins; M Raskind; E Peskind; S Plymate Journal: Ann N Y Acad Sci Date: 2000-04 Impact factor: 5.691
Authors: Peter T Nelson; Charles D Smith; Erin A Abner; Frederick A Schmitt; Stephen W Scheff; Gregory J Davis; Jeffrey N Keller; Gregory A Jicha; Daron Davis; Wang Wang-Xia; Adria Hartman; Douglas G Katz; William R Markesbery Journal: Biochim Biophys Acta Date: 2008-08-22
Authors: T den Heijer; S E Vermeer; E J van Dijk; N D Prins; P J Koudstaal; A Hofman; M M B Breteler Journal: Diabetologia Date: 2003-11-01 Impact factor: 10.122
Authors: Frédéric Calon; Giselle P Lim; Fusheng Yang; Takashi Morihara; Bruce Teter; Oliver Ubeda; Phillippe Rostaing; Antoine Triller; Norman Salem; Karen H Ashe; Sally A Frautschy; Greg M Cole Journal: Neuron Date: 2004-09-02 Impact factor: 17.173
Authors: Michelle Luciano; Narelle K Hansell; Jari Lahti; Gail Davies; Sarah E Medland; Katri Räikkönen; Albert Tenesa; Elisabeth Widen; Kevin A McGhee; Aarno Palotie; David Liewald; David J Porteous; John M Starr; Grant W Montgomery; Nicholas G Martin; Johan G Eriksson; Margaret J Wright; Ian J Deary Journal: Biol Psychol Date: 2010-12-03 Impact factor: 3.251
Authors: Richard Killick; Georgie Scales; Karelle Leroy; Mirsada Causevic; Claudie Hooper; Elaine E Irvine; Agharul I Choudhury; Laura Drinkwater; Fiona Kerr; Hind Al-Qassab; John Stephenson; Zehra Yilmaz; K Peter Giese; Jean-Pierre Brion; Dominic J Withers; Simon Lovestone Journal: Biochem Biophys Res Commun Date: 2009-06-10 Impact factor: 3.575